Ticker Symbol: NEXI
Neximmune Inc
$10.84 - 17-09-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001538210
Company Profile
NexImmune, based in Gaithersburg, Maryland, is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells to generate a specific, potent and durable immune response that mimics natural biology.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: www.neximmune.com
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.19
Change:
-$0.01
(
-5.65%)
Days Range: $0.19 - $0.20
Beta: 0.69
52wk. High: $20.35
52wk. Low: $3.50
Ytd. Change -19.67%
50 Day Moving Average: $5.05
200 Day Moving Average: $7.11
Shares Outstanding: 26078451
Valuation
Market Cap: 514.3M
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A